Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

Tumor-derived serum proteotypes to predict response to immune therapy in patients with limited disease small-cell lung cancer.

View Full Paper
Ask AI
Bookmark
Share

Authors

KHKrisztián HomicskóKAKarim AbdelhamidKVKaterina Vervita

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Homicskó et al. (2024) studied this question.

synapsesocial.com/papers/68e672e6b6db6435875fdc57https://doi.org/10.1200/jco.2024.42.16_suppl.8103
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dissecting Non-Small Cell Lung Cancer (NSCLC) with Blood Proteomics - From Surgical to Immunotherapeutic Responses2025
  2. 2High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC)2024 · 8 citations
  3. 3Plasma proteomics profiling identifies predictive biomarkers for immunotherapy response in small-cell lung cancer2025 · 3 citations
  4. 4Blood memory CD8 T cell phenotypes in lung cancer patients predict immune checkpoint treatment responses2025
  5. 5Proteomic characterization of small cell lung cancer uncovers innate-adaptive immune dynamics and immunotherapeutic vulnerabilities2026 · 1 citations